HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Diethylcarbamazine Citrate

HCID 15432
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
16354-46-4
Standard SMILES
CCN(CC)C(=O)N1CCN(C)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O
InChIKey
PGNKBEARDDELNB-UHFFFAOYSA-N
Molecular formula
C10H21N3O.C6H8O7
Average molar mass
391.42 g/mol
Monoisotopic mass
391.19546489

Overview

Diethylcarbamazine citrate is a crystalline solid, scored white tablets. Used against filariasis in man and animals. (EPA, 1998)

Names & identifiers

Preferred name
Diethylcarbamazine Citrate
IUPAC
N,N-diethyl-4-methylpiperazine-1-carboxamide;2-hydroxypropane-1,2,3-tricarboxylic acid

Names & synonyms

DIETHYLCARBAMAZINE CITRATE1642-54-2LoxuranDicarocideCaritrolFilazineFranocideFranozanCarbam PalatabsDitrazin citrateEthodryl citrateDirocide
Show more names
DitrazineDitrazinumFilarabitsLongicidDitrazini citrasDiethylcarbamazane citrateDiethylcarbamazine acid citrateDiethylcarbamazini citras

Database identifiers

CAS
16354-46-4、1642-54-2
PubChem CID
15432
DTXSID
DTXSID4045555
ChEMBL
CHEMBL937
ChEBI
CHEBI:4528
UNII
OS1Z389K8S
EC Number
216-696-6

Properties

Computed structural properties

Topological polar surface area
159 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
9
Rotatable bonds
7
Heavy atoms
27
Formal charge
0
Complexity
411

Experimental & physicochemical properties

OdorOdorless or slight odor
TasteBitter acid taste
Color/FormWhite, crystalline powder
Solubility · 4 items

> 75% in water @ 20 °C

Freely sol in hot alcohol

Sparingly sol in cold alcohol

Practically insoluble in acetone, benzene, chloroform and ether

Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Animal DrugsFDA approved animal drugs -> Active ingredient
DecompositionWhen heated to decomposition it emits ... fumes of nitrogen oxides.
Melting Point · 2 items

286 to 289 °F (EPA, 1998)

141-143 °C

Physical DescriptionDiethylcarbamazine citrate is a crystalline solid, scored white tablets. Used against filariasis in man and animals. (EPA, 1998)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P260, P264, P270, P271, P284, P301+P317, P304+P340, P316, P320, P330, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 40 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information · 2 items

Chemical: 1-Piperazinecarboxamide, N,N-diethyl-4-methyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)

Diethylcarbamazine citrate: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - 1-Piperazinecarboxamide, N,N-diethyl-4-methyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1): Environment tier I assessment
DOT LabelPoison
Fire HazardsWhen heated to decomposition, it emits toxic fumes of nitrogen oxides. Avoid decomposing heat. (EPA, 1998)
Health Hazards · 1 item

(Non-Specific -- Drugs, n.o.s.) May be fatal if inhaled, swallowed or absorbed through skin. Contact may cause burns to skin and eyes. Fire may produce irritating or poisonous gases. Runoff from fire control or dilution water may cause pollution. The average adult man tolerates a single dose of 1.5 gm without ill effects. (EPA, 1998)

Reactive GroupAlcohols and Polyols
Air and Water Reactions

Chemistry & industry

Pharmacology

Mechanism of Action · 3 items

The drug has two types of action on susceptible microfilariae. The first is to decrease the muscular activity and eventually immobilize the organisms; this may result from a hyerpolarizing effect of the piperazine moiety, and it causes dislocation of the parasites from their normal habitat in the host. The second action is to produce alterations in the microfilarial surface membranes, thereby rendering them more susceptible to destruction by host defense mechanisms. There is definite evidence that diethylcarbamazine kills adult worms of Loa loa and presumptive evidence that it kills adult Wuchereria bancrofti and Wuchereria malayi. However, it has little action against adult Onchocerca volvulus. The mechanism of the filaricidal action of diethylcarbamazine is unknown. /Diethylcarbamazine/

It is postulated that in naturally infected animals, diethylcarbamazine somehow promotes the combination of antigen and antibody on the surface of serotonin-rich platelets. Serotonin is released from damaged platelets, which dramatically increases vascular permeability and leads to shock. This generally but not always occurs in dogs with a high microfilaremia.

Diethylcarbamazine causes rapid disappearance of microfilariae of Wuchereriia bancrofti, Wuchereria malayi, and Loa loa from the blood of man. The drug causes microfilariae of Onchlcerca volvulus to disappear from the skin but does not kill microfilariae in nodules that contain the adult (female) worms. It does not affect the microfilariae of Wuchereria bancrofti in a hydrocele, despite penetration into the fluid.

Biological Half-Life... the plasma half-life /in man/ is about 8 hr after a 200 mg dose and 12 hr after an 800 mg dose.
Metabolism/MetabolitesOnly 10-25% of the drug is excreted unchanged; the remainder is excreted as one of four known metabolites, all of which contain the intact piperazine ring.
MeSH Pharmacological Classification · 2 items

Pharmacological agents destructive to nematodes in the superfamily Filarioidea.

Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Stability/Shelf Life
The product /as tablets/ is stable even under conditions of high temp and humidity.
Collision Cross Section144.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
Other Experimental Properties · 2 items

Slightly hygroscopic

A 6.29% w/v solution is iso-osmotic with serum.

No rapid reaction with air. No rapid reaction with water.
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Safety & protection

Fire FightingExcerpt from ERG Guide 154 [Substances - Toxic and/or Corrosive (Non-Combustible)]:
First AidWarning: Effects may be delayed up to 16 hours. Caution is advised.
Storage Conditions · 2 items

Preserve in tight containers.

Protect from light.

Nonfire Spill Response(Non-Specific -- Drugs, n.o.s.) Shut off ignition sources; no flares, smoking or flames in hazard area. Keep combustibles (wood, paper, oil, etc.) away from spilled material. Do not touch spilled material.
Disposal Methods · 1 item

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Isolation and EvacuationExcerpt from ERG Guide 154 [Substances - Toxic and/or Corrosive (Non-Combustible)]:
Personal Protective Equipment (PPE) · 1 item

For emergency situations, wear a positive pressure, pressure-demand, full facepiece self-contained breathing apparatus (SCBA) or pressure- demand supplied air respirator with escape SCBA and a fully-encapsulating, chemical resistant suit. (EPA, 1998)

Toxicology

Human Toxicity Excerpts · 3 items

Untoward direct reactions to diethylcarbamazine ... are not severe and usually disappear within a few days despite continuation of therapy. These include headache, general malaise, weakness, joint pains, anorexia, nausea, & vomiting. Other adverse effects result directly or indirectly from destruction of the parasites. These are especially severe in patients heavily infected with Onchocerce volvulus. In Wuchereria bancrofti or Loa loa infections, reactions are usually milder, although the drug may induce severe encephalitis in Loa loa. /Diethylcarbamazine/

In patients with onchocerciasis, there is usually a typical reaction within 16 hours after the first oral dose. This consists in intense itching & skin rashes, enlargement & tenderness of the inguinal lymph nodes, sometimes a fine papular rash, hyperpyrexia, tachycardia, and headache. These symtoms persist for 3 to 7 days and then subside, after which quite high doses can be tolerated. Ocular complications include limbitis, punctate keratitis, uveitis, and atrophy of the retinal pigment epithelium. Nodular swellings may occur along the course of the lymphatics, & there is often an accompanying lymphadenitis. This reaction also subsides within a few days. Almost all patients receiving therapy exhibit a leukocytosis, first evident on the second day, reaching its peak on the fourth or fifth day, & gradually subsiding over a period of a few weeks. Reversible proteinuria may occur, and the eosinophilia frequently observed in patients with filariasis can be intensified by drug therapy. /Diethylcarbamazine/

Four cases of persistent proteinuria and 3 cases of transient proteinuria are reported among 20 patients treated with diethylcarbamazine citrate, 2% topically or 50 mg orally.

Non-Human Toxicity Excerpts · 2 items

Diethylcarbamazine apparently has no adverse effect on fertility of male dogs. A number of studies in the USA to evaluate continued daily use in males have concluded that the drug causes no significant deterioration in quantity, morphology, motility, or viability of sperm. /Diethylcarbamazine/

Rapid metabolism and excretion of diethylcarbamazine probably accounts for its low toxicity. It is relatively nontoxic and side effects usually do not occur at the low dose (6.6 mg/kg) used for heartworm prevention. The greatest disadvantage of the drug is irritation to the gastric mucosa, which occurs especially when high doses (55-110 mg/kg) are used against ascarid infections of dogs and cats. /Diethylcarbamazine/

Non-Human Toxicity ValuesLD50 Rat oral 1.38 g/kg
Absorption, Distribution and Excretion · 1 item

Diethylcarbamazine is readily absorbed from the gastrointestinal tract. After a single oral dose of 200 to 400 mg, the concentration in plasma peaks in 1 to 2 hours ... Excretion is nearly all urinary, & more than 70% of the drug appears as metabolites. The compound is distributed almost completely throughout all body compartments with the exception of fat. Little accumulation occurs when repeated doses are given. /Diethylcarbamazine/

Uses & manufacturing

Uses · 2 items

MEDICATION (VET)

MEDICATION

Formulations/Preparations · 5 items

The drug is marketed as the dicitrate salt.

Vet: Some preperations (Styrid-Carcicide) contain not only diethylcarbamazine citrate but also as ingredient effective against the 3rd stage (infective) larvae of hookworms.

Vet: Diethylcarbamazine is prepared as either a syrup, powder, or tablet (chewable or nonchewable) and sold under several trade names.

Grade: USP

Diethylcarbamazine citrate tablets contain not less than 98.0% and not more than 100.5% of C10-H21-N3-0.C6-H8-0 calculated on the anhydrous basis.

General Manufacturing Information1-Piperazinecarboxamide, N,N-diethyl-4-methyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1): ACTIVE